Clinical Trial

HFNC for Postoperative Atelectasis After Laparoscopic Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Pneumoperitoneum and Trendelenburg positioning during laparoscopic surgery promote atelectasis development, which has been reported in up to 90% of patients under general anesthesia and increases the risk of postoperative pulmonary complications. High-flow nasal cannula (HFNC) oxygen therapy may reduce post-extubation atelectasis through alveolar recruitment. This prospective observational cohort study aims to evaluate the role of HFNC in postoperative atelectasis monitored by lung ultrasonography (LUS) in patients undergoing elective laparoscopic surgery.
Trial Details
NCT Number NCT07676760
Lead Sponsor Bursa Yuksek Ihtisas Training and Research Hospital
Conditions Postoperative Atelectasis, Postoperative Pulmonary Complications
Enrollment 90 participants
Start Date 2026-07
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-30